Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Jinhai Deng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The MondoA-dependent TXNIP/GDF15 1 axis predicts oxaliplatin response in colorectal adenocarcinomas.
Deng, J., Pan, T., Wang, D., Hong, Y., Liu, Z., Zhou, X., An, Z., Li, L., Alfano, G., Li, G., Dolcetti, L., Evans, R., Vicencio Bustamante, J., Vlckova, P., Chen, Y., Monypenny of Pitmilly, J., Araujo De Carvalho Gomes, C., Weitsman, G., Ng, K. & McCarthy, C. & 11 others, , 12 Sept 2024, In: EMBO Molecular Medicine. 16, 9, p. 2080-2108 29 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Citations (Scopus)3 Downloads (Pure) -
Exploration of Aging-Care Parameters to Predict Mortality of Patients Aged 80-Years and Above with Community-Acquired Pneumonia
Lv, C., Shi, W., Pan, T., Li, H., Peng, W., Xu, J. & Deng, J., 20 Sept 2022, (E-pub ahead of print) In: Clinical interventions in aging. 17, p. 1379-1391Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
Integrative pharmacogenomics revealed three subtypes with different immune landscapes and specific therapeutic responses in lung adenocarcinoma
Ge, X., Liu, Z., Weng, S., Xu, H., Zhang, Y., Liu, L., Dang, Q., Guo, C., Beatson, R., Deng, J. & Han, X., Jan 2022, In: Computational and Structural Biotechnology Journal. 20, p. 3449-3460 12 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans
Vicencio Bustamante, J., Evans, R., Green, R., An, Z., Deng, J., Treacy, C., Mustapha, R., Monypenny of Pitmilly, J., Costoya , C., Lawler, K., Ng, K., Desouza, K., Coban, O., Gomez, V., Clancy, J., Chen, S., Chalk, A., Wong, F., Gordon, P. & Savage, C. & 20 others, , 28 Mar 2022, In: Cell Death & Disease. 13, 3, 274 .Research output: Contribution to journal › Article › peer-review
Open AccessFile24 Citations (Scopus)198 Downloads (Pure) -
HER2-HER3 heterodimer quantification by FRET-FLIM and patient subclass analysis of the COIN colorectal trial
Barber, P. R., Weitsman, G., Lawler, K., Barrett, J., Rowley, M., Rodriguez-Justo, M., Fisher, D., Gao, F., Tullis, I. D. C., Deng, J., Brown, L., Kaplan, R., Hochhauser, D., Adams, R., Maughan, T. S., Vojnovic, B., Coolen, A. C. C. & Ng, T., 9 Sept 2020, In: Journal of the National Cancer Institute. 112, 9, p. 944-954 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile9 Citations (Scopus)337 Downloads (Pure)
Thesis
-
Chemotherapy induced immune-modulation via the TXNIP/GDF15 pathway in colorectal cancer
Deng, J. (Author), Sarker, D. (Supervisor) & Ng, T. C. (Supervisor), 1 Apr 2023Student thesis: Doctoral Thesis › Doctor of Philosophy
File